SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data from post-hoc…
Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of Life New Data…
Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic…
November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq:…
Data presented in an oral session at the Society for Immunotherapy of Cancer 39th Annual Meeting, where it was selected…
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity…
New data showed a correlation between the levels of neural cell adhesion molecule (NCAM or CD56) expression and response and…
November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp. MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT…
November 08, 2024 09:10 ET | Source: SEALSQ Geneva, Switzerland, Nov. 08, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES)…
CloudFirst Continues Strong Financial Performance Along with Expansion into the United Kingdom and Operational Success Following Flagship Solutions Group Integration…
